scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006383674 |
P356 | DOI | 10.1186/1742-2094-11-47 |
P932 | PMC publication ID | 3995780 |
P698 | PubMed publication ID | 24618100 |
P5875 | ResearchGate publication ID | 260716634 |
P2093 | author name string | Jian-Hong Zhu | |
Juan-Juan Zhu | |||
Ming Zou | |||
Xiong Zhang | |||
Li-Li Zhou | |||
Jian-Yong Wang | |||
Rong-Pei Liu | |||
Jun-Mei Lai | |||
Song-Fang Chen | |||
P2860 | cites work | Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3 | Q23914856 |
The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death | Q24644712 | ||
Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones | Q28285883 | ||
Involvement of the intracellular ion channel CLIC1 in microglia-mediated beta-amyloid-induced neurotoxicity | Q28575185 | ||
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains | Q29616293 | ||
Mechanisms underlying inflammation in neurodegeneration | Q29617977 | ||
Nitric oxide synthases: Roles, tolls, and controls | Q29618629 | ||
Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. | Q31900371 | ||
Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence | Q34062430 | ||
Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia | Q34130404 | ||
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia | Q34247698 | ||
The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease | Q34330121 | ||
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression | Q34904703 | ||
Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells | Q35031301 | ||
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. | Q35236618 | ||
Inflammation and neurodegeneration in Parkinson's disease | Q35756452 | ||
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. | Q36692860 | ||
Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice | Q37217248 | ||
Evidence for a cytokine model of cognitive function | Q37321439 | ||
Microglia: gatekeepers of central nervous system immunology. | Q37333298 | ||
The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain | Q37395741 | ||
Inflammation in neurodegenerative diseases | Q37766302 | ||
Depression in Parkinson disease--epidemiology, mechanisms and management. | Q37971293 | ||
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells | Q39541722 | ||
LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway--a potential role for neuroprotection | Q39742584 | ||
Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells | Q40030520 | ||
Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. | Q40410055 | ||
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production | Q40580069 | ||
Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells | Q40627929 | ||
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation | Q40891679 | ||
Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells | Q41052317 | ||
Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways. | Q42701827 | ||
Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease | Q43010410 | ||
Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection. | Q43945450 | ||
Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. | Q44242988 | ||
Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. | Q46729659 | ||
TLR signaling tailors innate immune responses in human microglia and astrocytes | Q57041985 | ||
Tolerability of paroxetine in Parkinson's disease: A prospective study | Q57203470 | ||
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms | Q64765320 | ||
Elevated plasma nitrate levels in depressive states | Q73605617 | ||
Double null of selenium-glutathione peroxidase-1 and copper, zinc-superoxide dismutase enhances resistance of mouse primary hepatocytes to acetaminophen toxicity | Q83195630 | ||
Inflammation in Parkinson's disease: cause or consequence? | Q84582822 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipopolysaccharide | Q421804 |
microglia | Q1622829 | ||
P304 | page(s) | 47 | |
P577 | publication date | 2014-03-12 | |
P1433 | published in | Journal of Neuroinflammation | Q15716679 |
P1476 | title | Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling | |
P478 | volume | 11 |
Q37310521 | A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders |
Q90464502 | Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury |
Q46627623 | Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways |
Q35179051 | Antidepressant compounds can be both pro- and anti-inflammatory in human hippocampal cells |
Q36437932 | Antidepressants Impact Connexin 43 Channel Functions in Astrocytes |
Q47642074 | Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes |
Q58750811 | Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine |
Q35190346 | EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation |
Q39600299 | Effects of a Standardized Phenolic-Enriched Maple Syrup Extract on β-Amyloid Aggregation, Neuroinflammation in Microglial and Neuronal Cells, and β-Amyloid Induced Neurotoxicity in Caenorhabditis elegans |
Q36667043 | GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways. |
Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
Q57285359 | Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma |
Q61453845 | Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease |
Q89554264 | Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes |
Q47940043 | Propofol attenuates BV2 microglia inflammation via NMDA receptor inhibition |
Q64859345 | Raf kinase inhibitor protein protects microglial cells against 1-methyl-4-phenylpyridinium-induced neuroinflammation in vitro |
Q26748711 | Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease |
Q60445723 | Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures |
Q48430028 | Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease |
Q38670012 | The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease |
Q35602606 | The role of the kynurenine pathway in suicidality in adolescent major depressive disorder |
Q41850897 | Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes |
Q37690930 | Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway |
Search more.